Using serum markers in the early diagnosis of myocardial infarction.
Because thrombolytic therapy can save lives and salvage left ventricular function after acute myocardial infarction, rapid and precise diagnosis is essential. Electrocardiographic changes, and the patient's history and physical examination may not confirm the diagnosis of myocardial infarction. Serum markers have specific advantages and disadvantages in confirming this diagnosis. An understanding of the advantages and disadvantages of using serum markers can enhance the clinician's ability to efficiently and accurately triage patients to appropriate care.
Chesebro
M J
MJ
University of Alabama School of Medicine, Huntsville, USA.
D015415:Biomarkers / Q000097:blood*; D003402:Creatine Kinase / Q000494:pharmacology*; D003937:Diagnosis, Differential; D006801:Humans; D007527:Isoenzymes; D007770:L-Lactate Dehydrogenase / Q000097:blood; D009203:Myocardial Infarction / Q000097:blood / Q000201:enzymology*; D009211:Myoglobin / Q000097:blood; D013997:Time Factors; D014336:Troponin / Q000097:blood
D015415:Biomarkers; D007527:Isoenzymes; D009211:Myoglobin; D014336:Troponin; D007770:L-Lactate Dehydrogenase; D003402:Creatine Kinase